AgingResearch.NewsJoin free

vTv Therapeutics

CompanyUnited StatesFounded 2015

Wikidata

vTv Therapeutics develops 2 assets, the furthest in phase 3 (cadisegliatin in type 1 diabetes). Mostly small molecule and other acting on glycolysis and gck; based in the United States, founded in 2015.

2
Assets
Furthest stage
Phase 3
Raised
US$80m
1
Trial
0
Signals

Pipeline

2

  • cadisegliatin

    Activates glucokinase in the liver to increase glucose uptake and improve blood glucose control.

    Phase 3, Small molecule, Glycolysis, gck, type 1 diabetes

  • HPPD

    Stage not known, Other

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms2
  • Trials1
  • Funding rounds and grants1
  • Similar companies6

Intelligence